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SUMMARY
Mesenchymal stromal cells are key components of hematopoietic niches in the bone marrow. Here we abrogated transforming growth
factor b (TGF-b) signaling in mesenchymal stem/progenitor cells (MSPCs) by deleting Tgfbr2 in mesenchymal cells using a doxycyclinerepressible Sp7 (osterix)-Cre transgene. We show that loss of TGF-b signaling during fetal development results in a marked expansion of
CXCL12-abundant reticular (CAR) cells and adipocytes in the bone marrow, while osteoblasts are significantly reduced. These stromal
alterations are associated with significant defects in hematopoiesis, including a shift from lymphopoiesis to myelopoiesis. However,
hematopoietic stem cell function is preserved. Interestingly, TGF-b signaling is dispensable for the maintenance of mesenchymal cells
in the bone marrow after birth under steady-state conditions. Collectively, these data show that TGF-b plays an essential role in the
lineage specification of fetal but not definitive MSPCs and is required for the establishment of normal hematopoietic niches in fetal
and perinatal bone marrow.

INTRODUCTION
The bone marrow microenvironment is uniquely adapted
to support hematopoiesis. A complex network of stromal
cells in the bone marrow provides key signals that support
the proliferation and survival of hematopoietic stem/
progenitor cells (Calvi and Link, 2015). CXCL12-abundant
reticular (CAR) cells are perivascular mesenchymal stromal
cells that express high levels of CXCL12 and stem cell factor (Sugiyama et al., 2006); they overlap considerably with
Leptin-receptor+ stromal cells (Zhou et al., 2014) and
Nestin-GFP+ stromal cells in the bone marrow (MendezFerrer et al., 2010). CAR cells and NG2+ arteriolar pericytes
produce cytokines and chemokines that play crucial roles
in regulating hematopoietic stem cells (HSCs), including
CXCL12 and stem cell factor (Ding and Morrison, 2013;
Ding et al., 2012; Greenbaum et al., 2013; Kunisaki et al.,
2013). Adipocytes are rare in the bone marrow at birth
but increase with aging and after myeloablation (Justesen
et al., 2001; Zhou et al., 2017). The presence of adipocytes
in the bone marrow negatively correlates with hematopoietic activity (Naveiras et al., 2009). However, a recent study
showed that adipocytes promote hematopoietic recovery
following myeloablation through production of stem cell
factor (Zhou et al., 2017), suggesting a context-specific
role for adipocytes in regulating hematopoiesis.
The development and maintenance of mesenchymal
stromal cells in the bone marrow is not well characterized.
Lineage tracing studies show that Sp7 (osterix)-cre-targeted
mesenchymal stem/progenitor cells (MSPCs) are present
in the perichondrium of the future hindlimb by embryonic

day 12.5 (E12.5) (Logan et al., 2002; Maes et al., 2010).
These fetal MSPCs transiently give rise to all mesenchymal
stromal cells in the bone marrow, including osteoblasts,
CAR cells, arteriolar pericytes, and adipocytes. However,
these stromal cells are gradually replaced during adulthood. Indeed, a distinct osterix-Cre-targeted MSPC population is present in neonatal bone marrow and gives rise to
long-lived mesenchymal stromal cells (Mizoguchi et al.,
2014). The signals regulating lineage specification of
MSPCs also are not well characterized. Omatsu and colleagues, in two separate studies, showed that Foxc1 and
Ebf1/Ebf3 contribute to the lineage specification of postnatal MSPCs. Specifically, the Foxc1 transcription factor
negative regulates adipocyte differentiation of postnatal
MSPCs, while the Ebf1/Ebf3 transcription factors inhibit
osteoblast differentiation (Omatsu et al., 2014; Seike
et al., 2018).
Transforming growth factor b (TGF-b) is an inflammatory
cytokine that also may contribute to MSPC differentiation.
Cell culture studies show that TGF-b negatively regulates
adipocyte and terminal osteoblast differentiation, while
stimulating osteoblast progenitor proliferation (Alliston
et al., 2001; Ignotz and Massague, 1985; Sparks et al.,
1992). Studies examining the role of TGF-b signaling in
MSPC differentiation in vivo are limited. Loss of Tgfb1 is
associated with bone loss and a deficiency of osteoblasts
(Tang et al., 2009). Tgfbr2, encoding TGF-b receptor 2, is
required for TGF-b signaling. Deletion of Tgfbr2 using
Prx1-Cre, which is active in early limb bud mesenchyme, results in severe skeletal defects and embryonic lethality (Seo
and Serra, 2007). Wang et al. (2013) used an osterix-Cre
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(Osx-Cre) transgene to delete Tgfbr2 in mesenchymal progenitors. They showed that Osx-Cre, Tgfbr2fl/fl mice have
impaired tooth development and reduced mineralization
of the mandible due to reduced osteoblast differentiation.
In humans, genetic alterations leading to enhanced
TGF-b signaling are associated with bone dysplasia in
Camurati-Engelmann disease (Wallace and Wilcox, 1993).
Of note, TGF-b regulates HSC quiescence and hematopoietic recovery following myeloablation (Brenet et al., 2013;
Yamazaki et al., 2011; Zhao et al., 2014). Whether TGF-b
signaling in mesenchymal stromal cells contributes to
these hematopoietic responses is an open question.
In this study, we characterize the contribution of TGF-b
signaling in MSPCs on the development of mesenchymal
stromal cells that comprise the bone marrow hematopoietic niche. We show that loss of TGF-b signaling in Osx-Cretargeted fetal MSPCs results in alterations in mesenchymal
stromal cells, including marked expansions of CAR cells
and adipocytes. Both canonical and noncanonical TGF-b
signaling in fetal MSPCs contribute to this phenotype.
The resulting alterations in mesenchymal stromal cells
are associated with a reduced capacity to support HSCs
and a shift in hematopoiesis from lymphopoiesis to myelopoiesis. Together, these data suggest that TGF-b plays a key
role in the lineage specification of MSPCs and is required
for the emergence of a normal hematopoietic niche during
fetal bone marrow development.

RESULTS
Deletion of Tgfbr2 in Osx-Cre-Targeted Mesenchymal
Cells Results in a Loss of Mature Osteoblasts
To investigate the role of TGF-b in the development and
maintenance of bone marrow mesenchymal stromal cells,
we deleted Tgfbr2 in mesenchymal cells using a doxycycline-repressible Sp7 (osterix)-Cre transgene (Osx-Cre)
(Maes et al., 2010). Previous studies have shown that OsxCre targets most mesenchymal stromal cells in the bone
marrow, including osteoblasts, adipocytes, pericytes, and
CAR cells, but not endothelial cells or hematopoietic cells.
Osx-Cre, Tgfbr2fl/fl male and female mice are severely runted
with a body weight less than 30% that of littermate controls (Figures 1A and 1B). Since most Osx-Cre, Tgfbr2fl/fl
died by 4 weeks of age, we focused our initial analysis of
mice at 3 weeks of age, when they appeared healthy.
The severe runting in Osx-Cre, Tgfbr2fl/fl mice suggested
impaired bone development. Indeed, micro-computerized
tomography (micro-CT) (Bouxsein et al., 2010) analysis of
male mice at 3 weeks of age showed significant reductions
in the bone volume and bone mineral density in trabecular
bone and a decrease in bone thickness and bone area in
cortical bone (Figure 1C). An increase in bone marrow

trabecularization also was observed by micro-CT (Figure 1D) and in histological sections (Figure S1A). Increased
trabecularization of the bone marrow can be seen with
impaired osteoclast activity. However, the serum level of
C-terminal telopeptide of type I collagen, a measure of
bone resorption (Bonde et al., 1995), was similar in
Osx-Cre, Tgfbr2fl/fl mice and control mice (Figure S1D).
Moreover, the number of TRAP+ osteoclasts and mRNA
expression in the bone marrow of the osteoclast-specific
genes, Acp5 (TRAP) and Ctsk (cathepsin K), was comparable
with control mice (Figures S1B and S1C). Thus, altered osteoclast function is not responsible for the bony defects in
Osx-Cre, Tgfbr2fl/fl mice.
We next examined osteoblasts using histomorphometry
of bone sections from Osx-Cre, Tgfbr2fl/fl Ai9 mice; these
mice express tdTomato in all mesenchymal bone marrow
stromal cells, including osteoblasts. The number of
tdTomato+ endosteal cells in the bone marrow of Osx-Cre,
Tgfbr2fl/fl Ai9 mice was reduced approximately 4-fold
compared with control mice (Figures 1E and 1F). Consistent with this finding, we also observed a consistent loss
of osteocalcin+ cells along the endosteum (Figure 1G).
There is in evidence from cell culture systems that TGF-b
signaling in osteoblast progenitors negatively regulates
terminal osteoblast differentiation in vitro. To examine
this in vivo, we generated DMP1-Cre, Tgfbr2fl/fl mice. We
previously showed that the DMP1-Cre transgene targets
mature osteoblasts and a subset of CAR cells that likely includes osteoblast progenitors (Zhang and Link, 2016).
DMP1-Cre, Tgfbr2fl/fl mice are not runted. Moreover, the
number of osteocalcin+ endosteal osteoblasts is normal
(Figure 1H), suggesting that TGF-b signaling is not required
for terminal osteoblast differentiation. Together, these data
suggest that TGF-b signaling in a mesenchymal progenitor
is required for the efficient development of mature
osteoblasts.
Deletion of Tgfbr2 in Osx-Cre-Targeted Mesenchymal
Cells Results in a Marked Increase in Bone Marrow
Adipocytes
Previous studies showed that TGF-b negatively regulates the
adipogenic differentiation of mesenchymal cell lines in vitro
(Choy and Derynck, 2003). We used osmium tetroxide
staining with micro-CT to visualize and quantify bone
marrow adiposity in Osx-Cre, Tgfbr2fl/fl mice at 3 weeks of
age, when bone marrow adiposity should be minimal
(Scheller et al., 2014). As expected in control mice, little
osmium staining was observed, mainly in the diaphyseal
region (Figure 2A). In contrast, osmium staining was seen
throughout the femur, and was increased nearly 80-fold in
Osx-Cre, Tgfbr2fl/fl mice (Figures 2A and 2B). Consistent
with this finding, a marked increase in oil red+ cells in the
bone marrow of Osx-Cre, Tgfbr2fl/fl mice also was observed
Stem Cell Reports j Vol. 13 j 48–60 j July 9, 2019 49

Figure 1. Loss of TGF-b Signaling in Mesenchymal Cells Inhibits Osteoblast Maturation
(A) Osx-Cre Tgfbr2fl/fl mouse and a littermate control mouse.
(B) Body weight at 3 weeks of age (n = 5).
(C) Micro-computed tomography (micro-CT) data showing bone volume density (BV/TV), bone mineral density (BMD), thickness, and bone
area (n = 4).
(D) Three-dimensional reconstruction of the micro-CT data in the diaphyseal region of a femur.
(E) Representative photomicrographs of the diaphyseal region of Osx-Cre, Ai9, and Osx-Cre Tgfbr2fl/fl Ai9 mice showing TdTomato+
osteoblasts (OB) lining the bone surface. Counterstaining with DAPI (blue) highlights nuclei.
(F) Quantification of endosteal TdTomato+ osteoblasts shown as fluorescence intensity per unit of bone surface area (n = 3).
(G) Representative photomicrographs showing osteocalcin expression (green).
(H) Representative photomicrographs showing osteocalcin expression (red) in femurs from Tgfbr2fl/fl and Dmp-1-Cre, Tgfbr2fl/fl mice.
Original magnification 203 for all images. Data represent the means ± SEM.
(Figure 2C). Finally, expression of several genes associated
with adipocyte differentiation was significantly increased
in the bone marrow of Osx-Cre, Tgfbr2fl/fl mice, including
50 Stem Cell Reports j Vol. 13 j 48–60 j July 9, 2019

peroxisome proliferator-activated receptor gamma (Pparg)
and fatty acid binding protein 4 (Fabp4) (Figure 2D). Collectively, these data show that loss of TGF-b signaling in

Figure 2. Loss of TGF-b Signaling in
Mesenchymal Cells Is Associated with
Increased Bone Marrow Adiposity
(A) Representative micro-CT images showing
osmium tetraoxide staining of femurs.
(B) Quantification of the osmium tetraoxide
signal (n = 5).
(C) Representative images of femur sections
stained with oil red (red). Original magnification, 103.
(D) RNA expression of the indicated gene
relative to b-actin mRNA is shown (n = 5–7).
Data represent the means ± SEM.

mesenchymal cells results in a massive increase in bone
marrow adiposity.
Deletion of Tgfbr2 in Osx-Cre-Targeted Mesenchymal
Cells Results in an Expansion of CAR Cells
The signals that regulate the development and maintenance of CAR cells are largely unknown. To assess the
impact of TGF-b signaling on CAR cell development and/or
maintenance, we generated Osx-Cre, Tgfbr2fl/fl Cxcl12gfp
mice. As expected, in control mice, CXCL12-GFP-bright
perivascular CAR cells were seen throughout the bone
marrow (Figure 3B). In Osx-Cre, Tgfbr2fl/fl Cxcl12gfp mice
the number of CAR cells was increased. Indeed, by
histomorphometry, CAR cell number was increased nearly
7-fold compared with control mice, and GFP expression per
CAR cell was increased (Figures 3B and 3C). Of note, the increase in CAR cells was not due to aberrant CXCL12-GFP
expression in adipocytes, since perilipin+ adipocytes did
not overlap with CXCL12-GFP bright (CAR) cells (Figure S2). Despite the increase in CAR cell number, total

bone marrow CXCL12 mRNA expression was significantly
decreased, suggesting that CXCL12 mRNA expression
per CAR cell is reduced (Figure 3A). Indeed, despite the increase in CXCL12-GFP expression (Figure 3B), a trend to
decreased CXCL12 mRNA expression (but not other niche
factors) was observed in CAR cells sorted from Osx-Cre,
Tgfbr2fl/fl Cxcl12gfp mice, suggesting that the mechanisms
regulating CXCL12-GFP expression are distinct from those
regulating endogenous Cxcl12 expression (Figure 3D).
These data show that loss of TGF-b signaling in mesenchymal cells results in an expansion of CAR cells that
have modestly reduced CXCL12 expression.
Deletion of Tgfbr2 in Osx-Cre-Targeted Mesenchymal
Cells Is Associated with Altered Hematopoiesis
We next examined the effect of the altered bone marrow
microenvironment in Osx-Cre, Tgfbr2fl/fl mice on hematopoiesis. Compared with controls, Osx-Cre, Tgfbr2fl/fl mice
displayed pancytopenia, with significant decreases in
the level of circulating neutrophils, B cells, and T cells
Stem Cell Reports j Vol. 13 j 48–60 j July 9, 2019 51

Figure 3. Loss of TGF-b Signaling in
Mesenchymal Cells Is Associated with an
Expansion of CAR Cells
(A) Total bone marrow RNA expression of
the indicated gene relative to b-actin mRNA
is shown (n = 5).
(B) Representative images of femur sections
showing GFP bright (green) CAR cells.
Original magnification 203.
(C) Quantification of CAR cells (n = 4).
(D) CXCL12-GFP-bright lineage cells were
sorted from the bone marrow of Osx-Cre
Tgfbr2fl/fl Cxcl12gfp or Tgfbr2fl/fl Cxcl12gfp
mice. RNA expression of the indicated gene
relative to b-actin mRNA is shown (n = 4–6).
Data represent the means ± SEM.

(Figures 4A and 4B). Furthermore, bone marrow and spleen
cellularity were reduced, even after normalizing to body
weight (Figures 4C–4F). In the bone marrow, a shift from
lymphopoiesis to myelopoiesis was observed, characterized
by a marked decrease in B cells and a modest increase, on a
percentage basis, in myeloid cells and granulocyte/macrophage progenitors, although the absolute number of each
hematopoietic cell population was reduced (Figures 4G,
4H, and S3A–S3C). On a percentage basis, phenotypic
HSCs (Kit+Sca1+lineageCD150+CD48 cells) were reduced
approximately 2-fold (Figures 4I and S3D). Due to bone
marrow hypocellularity, this resulted in a marked (approximately 10-fold) decrease in the total number of HSCs per
femur (Figure 4J). Even after adjusting for bone marrow
volume (total volume  bone volume), the total number
of phenotypic HSCs was reduced 2.8-fold in Osx-Cre,
Tgfbr2fl/fl mice (Figure 4K). Of note, the number of
Kit+Sca1+lineage cells in the spleen of Osx-Cre, Tgfbr2fl/fl
mice was markedly reduced, arguing against a migration
of hematopoietic progenitors from the bone marrow to
spleen (Figures S3E–S3H).
To assess HSC function, competitive repopulation assays
were performed using unpurified bone marrow cells.
Despite the decrease in phenotypic HSCs, multilineage
long-term repopulating activity of Osx-Cre, Tgfbr2fl/fl bone
marrow was comparable with control mice (Figure 4L).
Moreover, similar donor engraftment was observed
52 Stem Cell Reports j Vol. 13 j 48–60 j July 9, 2019

following secondary transplantation, suggesting that HSC
self-renewal is normal (Figure 4M). Collectively, these
data show that TGF-b signaling in mesenchymal progenitors is required for the development of a normal hematopoietic niche in the bone marrow. Specifically, the altered
bone marrow microenvironment in Osx-Cre, Tgfbr2fl/fl
mice is associated with a reduced capacity to support
hematopoiesis (in particular, B lymphopoiesis), but with
relatively preserved ability to support HSCs under basal
conditions.
Postnatal Deletion of Tgfbr2 in Osx-Cre-Targeted
Mesenchymal Cells Does Not Result in Impaired
Osteoblast or Adipocyte Development
A recent study suggested that mesenchymal stromal cells in
the bone marrow are derived from two distinct types of
MSPCs (Mizoguchi et al., 2014). Primitive or fetal MSPCs,
defined as Osx-Cre-targeted cells present in fetal bone on
E12.5, are responsible for osteoblasts and CAR cells
through approximately 3 weeks after birth. Definitive or
postnatal MSPCs, defined as Osx-Cre-targeted cells present
at birth, are responsible for the generation of osteoblasts,
CAR, and adipocytes cells in adult mice. To investigate
the contribution of TGF-b signaling in the lineage specification of definitive MSPCs, we characterized bone marrow
stromal cells in which Tgfbr2 was deleted postnatally by
removing doxycycline at birth. Consistent with a previous

Figure 4. Loss of TGF-b Signaling in Mesenchymal Cells Results in Perturbed Hematopoiesis
(A) Peripheral blood counts. WBC, white blood cells; RBC, red blood cells (n = 12).
(B) Number of neutrophils, B cells, and T cells in the blood is shown (n = 4).
(C–F) Spleen and bone marrow (BM) cellularity (per pelvis and combined lower limbs) (n = 4) (C and E) and after adjusting for body weight
(n = 4) (D and F).
(G–I) Percentage of the indicated cell type in the bone marrow is shown (n = 5): neutrophils and B cells (G), CMP (common myeloid
progenitor), GMP (granulocytes-macrophages progenitors), MEP (myeloid-erythrocytes progenitors) (H), and HSCs (c-kit+, lineage-, Sca1+,
CD150+, CD48- cells) (I).
(J and K) Shown is the absolute number of HSCs per pelvis and combined lower limbs (J) and HSC number after correcting for bone marrow
volume (K), which was estimated using micro-CT data as total volume (TV) of femur minus bone volume (BV) (n = 4).
(L) Competitive repopulation assays were performed with a 1:1 ratio of donor and wild-type competitor bone marrow. Shown is the
percentage of donor (Ly5.2) cells in peripheral blood (n = 15, from three independent experiments).
(M) Secondary transplantation was performed after 24 weeks. Shown is the percentage of donor (Ly5.2) cells in the secondary recipients
(n = 5). Data represent the means ± SEM.
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study, lineage tracing using Osx-Cre Tgfbrfl/fl Ai9 mice suggests that induction of Osx-Cre expression on postnatal
day 0 (P0) results in efficient targeting of osteoblasts and
CAR cells (Figure 5A) (Mizoguchi et al., 2014). Osx-Cre,
Tgfbr2fl/fl mice with postnatal Tgfbr2 deletion were of
normal size. Bone marrow cellularity was comparable (Figure S4D) with control mice, and no increase in bone
marrow trabeculae was observed (Figure 5B). Osteoblast
number, as measured by osteocalcin staining, was comparable with control mice (Figure 5C). Moreover, no increase
in perilipin+ cells was observed (Figure 5D). Consistent
with the lack of stromal changes, postnatal deletion of
Tgfbr2 had no effect on basal hematopoiesis (Figures S4A–
S4G). Collectively, these data suggest that TGF-b signaling
in definitive MSPCs is dispensable for lineage specification
in the early postnatal period.
TGF-b Signaling in Embryonic Osx-Cre-Targeted
Mesenchymal Progenitors Contributes to Osteoblast
Lineage Specification
The lack of major perturbations in mesenchymal stromal
cells in the bone marrow of postnatally deleted Osx-Cre,
Tgfbr2fl/fl mice suggested that TGF-b signaling in fetal
MSPCs may contribute to lineage specification. To explore
this possibility, we examined endochondral bone development in the hind limbs of Osx-Cre, Tgfbr2fl/fl Ai9 mice maintained off doxycycline, which results in constitutive OsxCre expression. We first examined mice at E14.5, at a time
just before the development of primary ossification centers. As reported previously, at this time point, the majority
of Osx-Cre-targeted (tdTomato+) cells localize to the perichondrium that surrounds hypertrophic chondrocytes at
the site of future long bones (Maes et al., 2010) (Figures
6A and 6B). Maes et al. showed that these osterix-expressing cells invade the cartilage and give rise to trabecular
osteoblasts and other bone marrow stromal cells. The number and perichondrial localization of Osx-Cre-targeted cells
in Osx-Cre, Tgfbr2fl/fl Ai9 mice was similar to control mice
(Figure 6B). Strikingly, even at this early stage of bone
development, a marked increase in perilipin+ cells was
observed in the bone collar of the developing hindlimb at
E14.5 of Osx-Cre, Tgfbr2fl/fl mice (Figure 6C). The increase
in perilipin+ cells in Osx-Cre, Tgfbr2fl/fl mice on E16.5 was
even more striking, with most Osx-Cre-targeted cells also
staining for perilipin (Figures 6D and S5D). However, OsxCre, Tgfbr2fl/fl chondrocyte number and distribution were
similar to littermate controls (Figures S5A and S5B).
To further assess the impact of TGF-b signaling on fetal
MSPC lineage specification, we sorted Osx-Cre-targeted
(TdTomato+) cells from the hind limbs of E16.5 Osx-Cre,
Tgfbr2fl/fl Ai9 or Osx-Cre Ai9 mice and performed RNA
expression profiling. Gene set enrichment analysis yielded
multiple hits for increased adipogenesis (Figure 6E).
54 Stem Cell Reports j Vol. 13 j 48–60 j July 9, 2019

Indeed, expression of key regulators or markers of adipogenesis, including Pparg, Plin2 (perilipin), Cd36, Fabp4,
and Adipoq (adiponectin) was increased in Osx-Cre,
Tgfbr2fl/fl Ai9 cells (Figure 6F). Interestingly, no alteration
in expression of osteoblast lineage genes was observed (Figure S5C). Together, these data suggest that TGF-b signaling
plays a key role in lineage specification of fetal MSCPs, suppressing adipogenesis while supporting osteoblast
development.
Noncanonical and Canonical TGF-b Negatively
Regulates Adipogenesis
Canonical TGF-b signaling depends on SMAD4 (Massagué,
2012). To investigate whether MSPC lineage specification
by TGF-b depends on SMAD4, we generated Osx-Cre,
Smad4flfl mice. Of note, canonical signaling by TGF-b and
other TGF family members, such as bone morphogen proteins and activins, are disrupted in these mice (Miyazawa
et al., 2002). Osx-Cre, Smad4fl/fl mice are runted to a similar
degree as Osx-Cre, Tgfbr2fl/fl mice. Also similar to Osx-Cre,
Tgfbr2fl/fl mice, Osx-Cre Smad4fl/fl mice displayed increased
trabecularization of their bone marrow cavity and a loss
of mature osteoblasts (Figures 7A and 7B). However, the
magnitude of the increase in bone marrow adiposity was
reduced in Osx-Cre Smad4fl/fl mice compared with OsxCre, Tgfbr2fl/fl mice as assessed by perilipin and oil red staining (Figures 7C, 7D, and S6).
These data suggested that noncanonical signaling contributes to the suppressive effect of TGF-b on adipogenesis.
To test this hypothesis, we generated cultures of mesenchymal stromal cells from wild-type neonatal bone marrow
(Figure 7E). Adipogenesis was induced by the inclusion of
dexamethasone, insulin, and indomethacin in the culture
media (CFU-A). As expected, in wild-type cultures, the
addition of TGF-b potently suppressed adipocyte formation, as measured by oil red staining (Figure 7F). Of note,
similar results were observed with mesenchymal stromal
cells derived from E16.5 hindlimbs (Figure S7). Noncanonical TGF-b signaling includes activation of mitogen-activated protein kinase (MAPK) (Zhang, 2009). To assess the
role of MAPK activation on the suppression of adipogenesis
by TGF-b, we pharmacologically inhibited MAPK activation in wild-type MSPC cultures. Inhibition of MAPK alone
did not suppress adipocyte formation. However, it
completely blocked the suppressive effect of TGF-b on adipogenesis (Figure 7F). Previous studies showed that phosphorylation of serine 82 of PPARg by MAPK decreases its
transcriptional activity (Camp and Tafuri, 1997). Since
PPARg is a master regulator of adipogenesis, we assessed
the ability of TGF-b to induce PPARg phosphorylation.
Indeed, the addition of TGF-b to the MSPC cultures resulted
in reproducible PPARg phosphorylation (Figures 7H and
7E). Collectively, these data suggest that TGF-b suppresses

Figure 5. TGF-b Signaling in Mesenchymal
Cells Postnatally Is Not Required for Osteoblast and Adipocyte Development
Doxycycline was removed at birth (postnatal
day) from Osx-Cre Tgfbr2D/D or control mice
to activate the Osx-Cre transgene.
(A) Representative image of Osx-Cre
Tgfbr2fl/fl, Ai9 femur sections showing
TdTomato (red) and DAPI (blue staining).
(B) Representative images of H&E-stained
femur sections.
(C) Representative images of osteocalcin
(green)-stained femur sections.
(D) Representative images of femur sections stained for perilipin (green) and
DAPI (blue). The far right panel shows a
femur section from an Osx-Cre Tgfbr2fl/fl
mouse maintained off doxycycline during
development, resulting in constitutive
Osx-Cre expression. Original magnification
203.

adipocyte specification of MSPCs, in part, in an MAPKdependent fashion through phosphorylation of PPARg.

DISCUSSION
In this study, we show that TGF-b signaling plays a key
role in the lineage specification of MSPCs during fetal
bone development. Specifically, loss of TGF-b signaling
in Osx-Cre-targeted MSPCs at sites of developing bones results in a marked expansion of adipocytes and CAR cells,
while mature osteoblasts are reduced. In contrast, deletion
of Tgfbr2 in Osx-Cre-targeted MSPCs at birth has no
apparent effect on mesenchymal cell lineage commitment. These data suggest that TGF-b signaling in fetal,
but not adult, MSPCs, plays a key role in lineage specification. Of note, the ability of TGF-b to suppress adipogenesis
in cultures MPSCs from fetal or postnatal day 1–4 bone
marrow was similar, suggesting that non-cell intrinsic
mechanisms may be responsible for the differential reliance on TGF-b in vivo. Whether differences in the level
of active TGF-b or the presence of other TGF-b family
members in the local microenvironment account for
this difference will require further study. Likewise, further
study is needed to define the importance of TGF-b
signaling on the response of bone marrow resident MSPCs
to aging or stressors, such as bone fracture or myeloablative therapy.

Previous studies have yielded mixed results with respect
to the role of TGF-b signaling in the regulation of osteoblasts (Alliston et al., 2001; Wu et al., 2016). Cell culture
studies suggested that TGF-b negatively regulates terminal
osteoblast differentiation (Alliston et al., 2001). Consistent
with these data, abrogation of TGF-b signaling in osteoblasts and osteoblast precursors in Ocn-Cre Tgfbr2fl/fl mice
is associated with an increased bone mass (Qiu et al.,
2010). However, our data show that constitutive deletion
of Tgfbr2 in MSPCs is associated with reduced bone mass
and a loss of osteoblasts. Moreover, we observed no change
in osteoblast number in DMP1-Cre Tgfbr2fl/fl mice, in which
TGF-b signaling is abrogated in mature osteoblasts and preosteoblasts (Zhang and Link, 2016). Although we did not
directly measure bone metabolism, these data suggest
that TGF-b signaling is dispensable for terminal osteoblast
differentiation. Of note, our data are consistent with a previous report showing that global loss of Tgfb1 is associated
with bone loss (Tang et al., 2009). Reconciling these disparate results is uncertain, but may be related to stage-specific
effects of TGF-b signaling on osteoblast development.
The mechanisms regulating MSPC differentiation into
adipocytes are not well understood. Our data show that
TGF-b is a potent negative signal regulating adipocyte specification in the developing bone marrow. Indeed, in the
absence of TGF-b signaling in fetal MSPCs, there is a striking increase in bone marrow adiposity. This phenotype is
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Figure 6. TGF-b Signaling Is Required for the Lineage Specification of Fetal Mesenchymal Stem/Progenitor Cells
(A) Schematic of bone development at E14.5 showing the perichondrial ‘‘bone collar’’ (red) surrounding hypertrophic chondrocytes (light
blue). The region imaged in (B) is shown.
(B) Representative images of E14.5 hindlimb sections showing TdTomato+ cells comprising the perichondrial collar. Original magnification 203.
(legend continued on next page)
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similar to that reported for mice whereby the transcription
factor Foxc1 is deleted in mesenchymal progenitors
(Omatsu et al., 2014). However, we observed no difference
in Foxc1 mRNA expression in sorted fetal MSPCs from
Osx-Cre, Tgfbr2fl/fl versus control mice (gene expression
normalized signal: 52.0 ± 6.0 versus 60.3 ± 7.3, respectively; p = 0.41). Previous studies have suggested that
TGF-b inhibits adipogenesis in cell lines in an SMADdependent fashion through repression of CCAAAT/
enhancer binding protein transcriptional activity, which
ultimately results in reduced PPARg mRNA expression
(Alliston et al., 2001). Consistent with this observation,
we observed increased PPARg mRNA in sorted fetal MSPCs
from Osx-Cre, Tgfbr2fl/fl mice. Furthermore, our data show
that SMAD-independent signaling also contributes to the
inhibition of adipogenesis by TGF-b. Consistent with previous studies, we show that activation of MAPK by TGF-b
results in phosphorylation of serine-82 of PPARg, which
is known to inhibit its transcriptional activity (Adams
et al., 1997; Camp and Tafuri, 1997; Han et al., 2000).
Indeed, we show that inhibition of MAPK abrogates the
ability of TGF-b to suppress adipocyte differentiation of culture primary MSPCs. Together, these data suggest that both
canonical and noncanonical TGF-b signaling contribute to
the lineage specification of MSPC in the bone marrow.
Our data suggest that TGF-b signaling plays an important
role in establishing hematopoietic niches in the bone
marrow. Significant alterations in three important stromal
components of the niche are altered in Osx-Cre, Tgfbr2fl/fl
mice. CAR cells, a key component of the stem cell niche,
are increased approximately 5-fold. However, despite the
increase in CAR cells, total bone marrow expression of
CXCL12 was modestly decreased. This can be explained,
in part, by reduced CXCL12 mRNA expression in CAR cells,
although loss of CXCL12 expression from other stromal
cell populations, such as osteoblasts, likely contributes to
the overall decrease in bone marrow CXCL12. Although
phenotypic HSCs are modestly reduced, functional HSCs,
as measured by long-term repopulating assays, were
normal after adjusting for bone marrow cellularity. Consistent with previous studies suggesting that osteoblasts are
a key component of the lymphoid niche in the bone
marrow (Ding and Morrison, 2013; Yu et al., 2016), a
prominent shift from lymphopoiesis to myelopoiesis
was observed in Osx-Cre, Tgfbr2fl/fl mice. Increased bone
marrow adiposity is associated with reduced hematopoietic
activity. Consistent with this observation, we observed
reduced bone marrow cellularity in Osx-Cre, Tgfbr2fl/fl

mice (even after adjusting for their reduced size). A recent
study showed that adipocytes are induced following myeloablation and contribute to hematopoietic recovery
(Zhou et al., 2017). TGF-b also is induced, raising the
possibility that increased TGF-b signaling may suppress
adipocyte expansion following myeloablation and limit
hematopoietic recovery.
In summary, our data suggest that TGF-b plays a key role
in the lineage specification of fetal MSPCs during development and is required for the proper development of fetal
hematopoietic niches in the bone marrow. The contribution of TGF-b signaling in MSPCs to the stromal and
hematopoietic response to different stressors is an active
area of investigation.

EXPERIMENTAL PROCEDURES
Experimental methods are briefly summarized. A detailed description is provided in Supplemental Information.

Mice
All mice were backcrossed onto a C57Bl/6 background and were
maintained under standard pathogen-free conditions according
to methods approved by the Washington University Animal
Studies Committee. All experiments were done using 3-week-old
mice unless stated otherwise. An equal number of male and female
mice were used.

Cell Sorting
Hindlimbs from E16.5 mice were homogenized and digested with
collagenase. TdTomato+ CXC12-GFP-bright, CD45 CDllb, Gr1,
B220 cells were sorted using a Sony iCyt Synergy SY3200 cell
sorter.

Micro-CT and Osmium Staining
Hindlimbs were incubated overnight at 4 C in 10% neutral buffered formalin and then embedded in 2% agarose. For osmium
staining, hindlimbs were fixed with 10% neutral-buffer formalin,
decalcified in 14% EDTA (pH 7.4), for 2 weeks, and then incubated
in 1% osmium tetroxide for 48 h at room temperature. Processed
tissues were scanned at 10-mm voxel resolution using a Scanco
mCT 40.

Immunostaining of Bone Sections
Mouse hindlimbs were fixed in 4% paraformaldehyde, decalcified,
incubated in 30% sucrose, and then embedded in optimal cutting
temperature compound. Twelve-micron tissue sections were incubated with the Avidin/Biotin Blocking Kit (Vector Laboratories)
and then incubated overnight with the indicated primary

(C and D) Representative images of E14.5 (C) or E16.5 (D) hindlimb sections from an Osx-Cre Ai9 (i) or Osx-Cre Tgfbr2fl/fl Ai9 (ii) mouse
stained for perilipin (green), CD31 to highlight the vasculature (white), and DAPI (blue).
(E and F) Microarray was performed on Osx-Cre-targeted (tdTomato+) cells from E16.5 hindlimbs (n = 4–6). Gene set enrichment analysis
identified increased adipogenesis in cells from Osx-Cre Tgfbr2fl/fl Ai9 mice (E). Heatmap of selected adipocyte marker genes (F).
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Figure 7. TGF-b Regulates Adipogenesis through Canonical and Noncanonical Pathways
(A) Representative images of H&E-stained femur sections. Original magnification 103.
(B) Representative images of osteocalcin (red)-stained femur sections.
(C) Representative images of perilipin (green)-stained femur sections. DAPI (blue). Original magnification 403.
(legend continued on next page)
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antibodies overnight at 4 C. Images were acquired using an LSM
700 confocal microscope (Carl Zeiss Microscopy) and processed
using Volocity software (PerkinElmer).
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Mesenchymal Stromal Cell Culture
Hindlimbs bones from mice at E16.5 or P1–4 were mechanically
disrupted and cultured overnight. Nonadherent cells were
removed after 24 h. To induce adipogenesis, dexamethasone
(100 nM), insulin (5 mg/mL), and indomethacin (50 mM) were
added to the culture media for 5 days. Where indicated, recombinant murine TGF-b (20 ng/mL) and/or a combination of two
MAPK inhibitors, U0126 (20 mM) and PD98059 (20 mM), were
included in the cultures 24 h before inducing adipogenesis.

Statistical Analysis
Significance was determined using PRISM software (GraphPad),
except in the case of the RNA expression profiling data, which
was analyzed using the Affymetrix Transcriptome Analysis Console. For single-parameter analysis, unpaired t tests were used to
assess statistical significance. For multiple parameter data, statistical significance was calculated using one-way or two-way ANOVA.
The number of replicates (n) refers to individual mice, unless otherwise indicated. p values <0.05 were considered significant.
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SUPPLEMENTAL FIGURE LEGENDS
Figure S1. Related to Figure 1. Loss of TGF-β signaling in mesenchymal cells does not alter osteoclasts. A.
Representative photomicrographs of H&E stained femur sections from Tgfbr2flfl and Osx-CreTgfbr2flfl mice. B.
Representative photomicrographs of femur sections stained with tartrate-resistant acidic phosphatase (TRAP, red).
Original magnification 20X. C. RNA expression of the indicated osteoclast marker gene relative to β-actin mRNA is
shown (n=5)
Osteoclasts functional genes marker of total bone marrow mRNA expression relative to β-actin. D. Serum C-terminal
telopeptide of type I collagen (CTX-1) (n = 11-12). Data represent the mean ± SEM.
Figure S2. Related to Figure 3. CAR cells are distinct from perilipin+ adipocytes. (A, B) Representative
images of femur sections from Tgfbr2fl/fl Cxcl12gfp mice showing CXCL12-GFP (green), perilipin (red), and DAPI
(blue).
Figure S3. Related to Figure 4. Loss of TGF-β signaling in mesenchymal cells results in perturbed
hematopoiesis. A-B. The absolute number of the indicated cell type per pelvis and combined lower limbs is shown
(n = 5). CMP, (common myeloid progenitor), GMP (granulocytes-macrophages progenitors), and MEP (myeloiderythrocytes progenitors). C. Representative dot plots showing the gating strategy to identify CMP, GMP, and MEP;
data are gated on c-Kit+, lineage-, Sca1- cells. D. Representative dot plots showing the gating strategy to identify
HSCs; data are gated on c-Kit+, lineage-, Sca1+ cells. RP, restricted progenitors, MPP, multipotent progenitors. E-F.
Percentage and absolute number of bone marrow KSL cells. G-H. Percentage and absolute number of spleen KSL
cells.
Figure S4. Related to Figure 5. Post-natal deletion of Tgfbr2 in mesenchymal cells is not required for basal
hematopoiesis. A. Peripheral blood counts. WBC, white blood cells; and RBC, red blood cells (n=6). B. Number of
neutrophils, B cells, and T cells in the blood is shown (n=6). C-D. Spleen and bone marrow cellularity (per femur)
(n=6). E. Number of neutrophils and B cells per femur. F. Number of HSC-LT (Lin- kit+ Sca1+ CD48- CD150+ Flt3) and HSC-ST (Lin- kit+ Sca1+ CD48- CD150- Flt3-) per femur. G. Number of MMP2 (Lin- kit+ Sca1+ CD48+ CD150+
Flt3-), MMP3 (Lin- Ckit+ Sca1+ CD48+ CD150- Flt3-), and MPP4 (Lin- kit+ Sca1+ CD48+ CD150- Flt3+).
Figure S5. Related to Figure 6. TGF-β signaling in Osx-Cre targeted mesenchymal progenitors is not required
for chondrocyte development. A-B. Representative images E14.5 (A) or E16.5 (B) hindlimb sections from Tgfbr2fl/fl
(i) or Osx-Cre, Tgfbr2fl/fl (ii) mice showing aggrecan (green, chondrocytes), CD31 (white, vasculature) and DAPI
(blue, nuclei) staining. C. RNA expression profiling was performed on sorted TdTomato+ lineage- cells isolated from
the hindlimb of E16.5 Osx-Cre Ai9 and Osx-Cre, Tgfbr2fl/fl Ai9 mice. Shown are log2 probe signals for Bglap, Alp,
Runx1 and Sp7. D. Osterix-Cre targeted mesenchymal cells express perilipin. Representative images of E16.5 fetal
hindlimb sections from Osx-Cre, Tgfbr2fl/fl Ai9 mice showing tdTomato (red, Osx-Cre targeted cells), CD31 (white,
vasculature), perilipin (green, adipocytes cells) and DAPI (blue, nuclei) staining. Original magnitude 20X.
Figure S6. Related to figure 7. Loss of Smad4 in Osx-Cre targeted mesenchymal cells results in altered
adipogenesis. Representative images of femur sections showing oil red staining. Original magnification, 20X.
Figure S7. Related to figure 7. TGF-β suppresses adipogenesis of cultured fetal mesenchymal progenitors.
Mesenchymal progenitors were isolated from wildtype E16.5 hindlimbs and cultured for 7 days in the (media)
presence of dexamethasone, insulin and indomethacin to induce adipocyte differentiation (CFU-A). Where indicated,
TGF-β was included in the culture. Shown are representative images of cultures stained for oil red to show adipocytes.
Table S1. Related to figure 6. Differentially expressed genes in Osx-Cre targeted (tdTomato+) cells from E16.5
hindlimbs.
Experimental Procedure
Contact for Reagents and Resource Sharing
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead
Contact, Daniel C. Link (danielclink@wustl.edu).

Experimental Model and Subject Details
Mice and Animal Housing
Osx1-GFP::Cre (Rodda and McMahon (2006), Ai9 (Madisen, Zwingman et al. 2010), TβRII fl/fl (Leveen 2002), Dmp1cre (Lu, Xie et al. 2007), and Smad4 fl/fl (Smad4tm2.1Cxd/J) mice were obtained from The Jackson Laboratory. Cxcl12gfp
mice (Nagasawa, Hirota et al. 1996) were a gift from Dr.Takashi Nagasawa (Kyoto University, Japan). Mice were
crossed in-house to generate Osx-Cre Tgfbr2flfl, Osx-Cre Tgfbr2flfl/Ai9, Osx-Cre Tgfbr2flflCxcl12gfp, Osx-CreAi9, Dmp-1Cre Tgfbr2flfl, and Osx-Cre Smad4flfl Ai9 mice on a C57Bl/6 background. To suppress the Osx-Cre transgene, mice
were maintained on doxycycline chow (200 mg/serving). All experiments were done using 3 weeks old mice unless
stated otherwise. An equal number of male and female mice were used. Mice were maintained under standard
pathogen-free conditions according to methods approved by the Washington University Animal Studies Committee.
Flow cytometry
Peripheral blood, bone marrow, and spleen mononuclear cell preparations were lysed in Tris-buffered ammonium
chloride (pH 7.2) buffer for 5 minutes at 4°C. Cells were then incubated with the indicated antibody at 4°C for 30
minutes in phosphate buffered saline (PBS) containing 1mM ethylenediaminetetraacetic acid (EDTA) and 0.2%
(weight/volume) bovine serum albumin (BSA). The HSPC panel included Pe-Cy7-conjugated CD117 (2B8); BV711conjugated Ly-6A/E; BV605-conjugated CD150 (TC15-12F12.2) BV421-conjugated CD48 (HM48-1); APCconjugated CD16/32 (2.4G2); FITC-conjugated CD34 (RAM34); and PE-conjugated CD135 (A2F10.1) and the
following APC-Cy7-conjugated antibodies: CD3e (145-2C11), B220 (RA3-6B2), Gr1 (RB6-8C5), Ter119 (TER119), and CD11b (M1/70). The CAR cell panel included the following BV421-conjugated antibodies against CD45
(30-F11), B220, Gr1, and CD11b. Cells were acquired using a FACSAria III flow cytometer (BD biosciences, San
Jose, CA, USA) and analyzed using FlowJo software.
Cell sorting
Hindlimbs and forelimbs from embryonic day E16.5 were homogenized in PBS using a mortar and pestle. The cell
suspension was then incubated in PBS containing 1.7 mg/ml collagenase type 1 (#17100017, ThermoFisher, Waltham,
MA, USA), 1.7 mg/ml collagenase type 2 (#LS004174, Worthington, Lakewood, NJ, USA), and 1.7 mg/ml
collagenase type 4 (#LS004188, Worthington) at 37°C while shaking for 10 minutes. The resulting cell suspension
was filtered through CellTrics 50µm filters (Sysmex, Goerlitz, Germany) to remove cell clumps and then incubated
at 4°C for 30 minutes in PBS containing 1mM EDTA and 0.2% BSA with the following panel of FITC-conjugated
lineage antibodies: CD45, Gr1, CD11b, and B220. Tdtomato+ lineage- cells were sorted using a Sony iCyt Synergy
SY3200 (Synergy)” cell sorter (Sony, San Jose, CA, USA). CXCL12-GFP-bright CD45- lineage- cells were sorted
from Osx-Cre Tgfbr2flflCxcl12gfp or Tgfbr2flflCxcl12gfp mice using a similar strategy.
Micro-computed tomography and osmium staining
Hindlimbs were incubated overnight at 4°C in 10% neutral buffered formalin and then embedded in 2% agarose.
Femurs were scanned at 10μm voxel resolution, using a Scanco μCT 40 (Scanco Medical, Wayne, PA) calibrated
using a hydroxyapatite phantom. Measurements of both cancellous and cortical bones were made based on reported
guidelines (Bouxsein, Boyd et al. 2010). For cancellous bone, 100 slices (1mm) proximal to the growth plate (GP)
were contoured to exclude the cortical bone, allowing cancellous bone volume/tissue volume (BV/TV) and bone
mineral density (BMD) to be determined. For cortical bone, 20 slices (200 μm) located mid-diaphysis were
contoured to exclude the marrow space and analyzed to determine cortical tissue mineral density (TMD) and
cortical bone thickness. A threshold of 260 for cortical bone (on a 0–1000 scale) was maintained. For cancellous
bone, a threshold of 175 was used for μCT. An additional analysis of cancellous bone was performed within the
cortical bone region of interest after discovering the presence of cancellous bone mid-diaphysis in the mutant, but
not control bones. Like cancellous bone at the GP, femurs were contoured to exclude the cortical bone and a
threshold of 175 was maintained.
For osmium staining, hindlimbs were fixed with 10% neutral-buffer formalin, washed with water and
decalcified in 14% EDTA, Ph 7.4, for 2 weeks. After washing again with water, 600μl Sorensen’s phosphate buffer
(pH 7.4) was added and then the hindlimbs incubated in a fume hood with 1% osmium tetroxide for 48 hours at
room temperature. Hindlimbs were washed three times by incubating in 1 ml of Sorensen’s buffer for 3 hours at
room temperature with the last wash including an overnight incubation at room temperature.
Immunostaining of bone sections
Mouse hindlimbs were fixed in PBS containing 4% paraformaldehyde, pH 7.4, for 24 hours at 4°C. Bones were then
decalcified in PBS containing 14% EDTA, pH 7.4, for 7 days at 4°C. Following incubation in PBS containing 30%

sucrose for 24 hours at 4°C, bones were embedded in optimal cutting temperature compound (OCT) (Sakura Finetek,
Torrance, CA, USA). The tissue blocks were cut into 12µm sections using a Leica Cryo-Jane system (Leica
Biosystems, Wetzlar, Germany). For immunostaining, the slides were first incubated in 0.1M Tris-Cl pH 7.5, 150mM
NaCl, and 0.1% Tween 20 (TNT) buffer containing 10% donkey serum for 1 hour at room temperature. Sections were
then incubated for 15 minutes at room temperature using the Avidin/Biotin Blocking Kit (SP-2001; Vector
Laboratories, Burlingame, CA, USA). Sections were incubated with the primary antibody overnight at 4°C and, where
applicable, then incubated with the secondary antibody at a 1 to 100 dilution for 1 hour at room temperature. The
following antibodies were used: rabbit anti-perilipin at a 1:800 dilution (MilliporeSigma), anti-PECAM-1 at a 1:100
dilution (clone 2H8, MilliporeSigma), rabbit anti-aggrecan at a 1:100 dilution (AB1031, MilliporeSigma), and rabbit
anti-osteocalcin at a 1:50 dilution (ab10911, ABCAM, Cambridge, United Kingdom). Finally, slides were mounted
with ProLong Gold antifade reagent with DAPI (Life Technologies, Inc., Grand Island, NY, USA). Images were
acquired using an LSM 700 confocal microscope (Carl Zeiss Microscopy, Peabody, MA, USA) and processed using
Volocity software (PerkinElmer, Waltham, MA, USA).
Hematoxylin and eosin (H&E) staining of bone sections was performed using the Hematoxylin and Eosin
Stain Kit (Vector Laboratories Burlingame, Ca. USA, Cat# H-3502). Oil red staining was performed using the Sigma
Oil Red O kit per manufacturer’s recommendations (MilliporeSigma). Sections were mounted with Organo/Limonene
Mount™ (MilliporeSigma), and images were acquired using an Hamamatsu Nanozoomer (Hamamatsu Photonics,
Hamamatsu City, Japan).
Quantitative reverse-transcription PCR
Total bone marrow RNA was obtained by flushing femurs with 1 ml of Trizol (Invitrogen). RNA was prepared
according to the manufacturer’s specification. One-step quantitative reverse-transcription PCR was performed using
the TaqMan Universal PCR Master Mix (Applied Biosystems) using no template and no reverse-transcription controls.
Data was collected on a 7300 Real-Time PCR System (Applied Biosystems). Oligonucleotides are provided in the
Key Resource.
RNA expression profiling
RNA was purified from sorted mesenchymal cells using the NucleoSpin® RNA XS kit per manufacturer’s
recommendations (MACHEREY-NAGEL, Düren, Germany). Libraries were prepared using the Affymetrix WT Pico
kit per manufacturer’s recommendations (Affymetrix, Waltham, MA, USA) and then hybridized onto Affymetrix
Clariom S arrays. The arrays were placed in a GeneChip Hybridization Oven 640 for 18 hours at 45°C, and then they
were washed and stained in an Affymetrix Fluidics Station 450. The arrays were scanned using the Affymetrix
GeneChip 7G 3000 Scanner. Data were analyzed on an Affymetrix GeneChip Command Console to generate CEL
files. Affymetrix Transcriptome Analysis Console (TAC) software was used to treat the CEL files through Robust
Multichip Analysis (RMA) algorithm, including probe-set signal integration, background correction and quantile
normalization. TAC software also was used to identify differentially expressed genes. In this study, differentially
expressed genes were defined by the following criteria: 1) false discovery rate (FDR) of ≤ 7.5%; 2) fold-change of ≥
2; and 3) a minimum probe signal of 50 in the upregulated group. To identify the significantly enrichment of gene
ontology (GO) terms and functional pathways, DAVID (http://david.abcc.ncifcrf.gov/tools.jsp), Kyoto Encyclopedia
of Genes and Genomes (KEGG, http://www.genome.jp/kegg/), and pre-ranked Gene Set Enrichment Analysis
(GSEA, http://software.broadinstitute.org/gsea/index.jsp) were used.
Mesenchymal stromal cell culture
Mice were sacrificed on embryonic day 16.5 (E16.5) or 1-4 days after birth, and hindlimb bones were harvested.
Bones were mechanically disrupted in complete Dulbecco’s modified eagle medium (DMEM) plus 20% fetal bovine
serum (FBS) and penicillin-streptomycin using a mortar and pestle. The resulting cell suspension was cultured
overnight at 37°C with 5% CO2, and the following day non-adherent cells removed by gentle aspiration. Cells were
cultured until reaching approximately 40% confluence (generally, 5-6 days). To induce adipogenesis, dexamethasone
(100nM), insulin (5 μg/ml), and indomethacin (50 mM) were added to the culture media for 5 days. Where indicated,
recombinant murine TGF-β (20ng/ml) and/or a combination of two MAPK inhibitors, U0126 (20 μM) and PD98059
(20 μM), were included in the cultures 24 hours prior to inducing adipogenesis.
Western Blot
Total cellular protein was isolated from culture mesenchymal cells using RIPA lysis buffer (#20-188, MilliporeSigma)
inhibiting for protease and phosphatase (#78440, ThermoFisher). Twenty µg of protein was separated using pre-cast
4-15% gradient SDS gels (#456-1084, Bio-Rad) and transferred to nitrocellulose membranes (#IPVH00010.

Millipore). Membranes were incubated with a 1:1000 dilution of rabbit anti-PPARγ (PA3-821A, MilliporeSigma) or
a 1:1000 dilution of rabbit anti-phospo (Ser82)-PPARγ) (#04-816, MilliporeSigma) in Tris buffered saline 100mM
Tris HCl, 1.5M NaCl, pH 7.5 (TBS) (#Ρ029, G-biosciences, Saint Louis, MO, USA) and 5% BSA (TBS) overnight at
4oC. Following multiple TBS washes, the membranes were incubated with a 1:5000 dilution of horseradishperoxidase-conjugated anti-rabbit antibody (#A0545, MilliporeSigma) for 1 hour at room temperature. Following
incubation with a chemiluminescence horse radish peroxidase substrate (Millipore, #WBKLS0100), the membranes
were imaged using the Bio-Rad ChemiDoc XRS+ (BIO-RAD, Hercules, CA, USA.).
Quantification and Statistical Analysis
Significance was determined using PRISM software (GraphPad), except in the case of the RNA expression profiling
data, which was analyzed using the Affymetrix Transcriptome Analysis Console. For single parameter analysis,
unpaired t-test were used to assess statistical significance. For multiple parameter data, statistical significance was
calculated using one-way or two-way analysis of variance (ANOVA). P values less than 0.05 were considered
significant.
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